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Abstract
Objective To investigate the effect of an additional review based on
reporting guidelines such as STROBE and CONSORT on quality of
manuscripts.
Design Masked randomised trial.
Population Original research manuscripts submitted to the Medicina
Clínica journal from May 2008 to April 2009 and considered suitable for
publication.
Intervention Control group: conventional peer reviews alone. Intervention
group: conventional review plus an additional review looking for missing
items from reporting guidelines.
Outcomes Manuscript quality, assessed with a 5 point Likert scale
(primary: overall quality; secondary: average quality of specific items in
paper). Main analysis compared groups as allocated, after adjustment
for baseline factors (analysis of covariance); sensitivity analysis compared
groups as reviewed. Adherence to reviewer suggestions assessed with
Likert scale.
Results Of 126 consecutive papers receiving conventional review, 34
were not suitable for publication. The remaining 92 papers were allocated
to receive conventional reviews alone (n=41) or additional reviews (n=51).
Four papers assigned to the conventional review group deviated from
protocol; they received an additional review based on reporting
guidelines. We saw an improvement in manuscript quality in favour of
the additional review group (comparison as allocated, 0.25, 95%
confidence interval –0.05 to 0.54; as reviewed, 0.33, 0.03 to 0.63). More
papers with additional reviews than with conventional reviews alone
improved from baseline (22 (43%) v eight (20%), difference 23.6% (3.2%
to 44.0%), number needed to treat 4.2 (from 2.3 to 31.2), relative risk
2.21 (1.10 to 4.44)). Authors in the additional review group adhered more
to suggestions from conventional reviews than to those from additional
reviews (average increase 0.43 Likert points (0.19 to 0.67)).
Correspondence to: E Cobo erik.cobo@upc.edu
Extra material supplied by the author (see http://www.bmj.com/content/343/bmj.d6783?tab=related#webextra)
Web appendix: Protocol trial design
Web table 1: Manuscript quality assessment instrument
Web table 2: Adherence recommendation assessment questionnaire
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Research
RESEARCHConclusions Additional reviews based on reporting guidelines improve
manuscript quality, although the observed effect was smaller than
hypothesised and not definitively demonstrated. Authors adhere more
to suggestions from conventional reviews than to those from additional
reviews, showing difficulties in adhering to high methodological standards
at the latest research phases. To boost paper quality and impact, authors
should be aware of future requirements of reporting guidelines at the
very beginning of their study.
Trial registration and protocol Although registries do not include trials
of peer review, the protocol design was submitted to sponsored research
projects (Instituto de Salud Carlos III, PI081903).
Introduction
The scientific value of biomedical journals relies on the peer
review process and on editorial decisions, but the quality of
these processes is far from guaranteed.
1-4 Processes, be they in
patient care or in peer review, can be improved through
interventions, which are then evaluated by trials. In 1992,
Drummond Rennie
5 called for scientific proof of the value of
the peer review system. A Cochrane review updated in 2007
6
concluded that little evidence supports the effectiveness of
scientific peer review, since most studies tested the specific
effects of masking either authors or reviewers. Investigators
have also attempted to improve the quality of peer review,
7
reducereviewerburden,
8lessenreviewerbias,
9andimprovethe
detection of fraud.
10 However, only two of these studies were
randomised controlled trials, and all of them focused on
surrogate variables related to the review process and not on the
true outcome: manuscript quality.
In recent years, the need to establish common, minimum
standards of quality resulted in the development of reporting
guidelines. These guidelines are defined as: “statements that
provide advice on how to report research methods and findings
. . . they specify a minimum set of items required for a clear and
transparent account of what was done and what was found in a
research study, reflecting in particular issues that might
introduce bias into the research.”
11 Specific guidelines have
been developed for different kinds of medical investigation,
such as those estimating intervention effects (CONSORT
(consolidated standards of reporting trials),
12 TREND
(transparent reporting of evaluations with non-randomised
designs)
13), assessing causes and prognosis (STROBE
(strengthening the reporting of observational studies in
epidemiology)
14), quantifying accuracy of diagnosis and
prognosis tools (STARD (standards for the reporting of
diagnostic accuracy studies),
15 REMARK (reporting
recommendations for tumour marker prognostic studies)
16),
testing genetic associations (STREGA (strengthening the
reporting of genetic associations)
17), and aggregating evidence
(PRISMA(preferredreportingitemsforsystematicreviewsand
meta-analyses)
18). Some reporting guidelines have been shown
to improve the quality of reports, such as CONSORT.
19 20
Our team at the Medicina Clínica journal previously undertook
two randomised trials to determine whether adding a statistical
reviewer had any effect on final manuscript quality; the first
trial
21 suggested a positive benefit that was confirmed in the
second.
22 This second trial also investigated the effect of
suggesting the use of reporting guidelines to reviewers, but did
not observe any benefit.
The present study focuses on the merged effects of statistical
reviews and reviewing guidelines. The intervention consisted
ofanadditionalreviewfromaseniorstatisticianaskingauthors
to provide information about incomplete or missing items from
reporting guidelines. This additional review was possible
because the launch of the STROBE guideline in 2007 allowed
us to systematically apply a reporting guideline to almost any
papersubmittedtoMedicinaClínica.Thus,weaimedtoquantify
theeffectsofanadditionalreviewbasedonreportingguidelines
on the quality of the final manuscript in a weekly medical
journal with no specific requirements to follow reporting
guidelines. After analysis of the overall results, we considered
another hypothesis: when updating their manuscript, would
authors adhere more to suggestions based on conventional
reviews, rather than to those based on reporting guidelines?
Methods
Study design and population
Thestudywasarandomisedtrialandthewebappendixprovides
full details of the trial protocol. Medicina Clínica is a weekly
journal based in Barcelona, Spain, with an impact factor of 1.4
that receives more than 300 original papers each year and
publishes about a third of submissions. The journal did not ask
authors to adhere to reporting guidelines. The current editors
(MV and CRJ) assumed their roles on the journal in January
2000, and have since recruited AS, AU, VF, and EC. The two
general secretaries (JMR and FC) have more than 15 years’
experience.
During the selection process, the first editorial decision chose
which papers were sent to reviewers (fig 1⇓). The second
decision selected which papers were returned to authors for
improvement. We defined the study population as all original
researchmanuscriptsreceivedbyMedicinaClínicafrom1May
2008 to 30 April 2009 that successfully passed through the
second editorial decision after conventional peer review.
Intervention
All papers were reviewed by the usual referee team (usually
two clinicians, or one clinician with either one statistician or
oneepidemiologist).Manuscriptsintheinterventiongroupalso
received an additional review based on reporting guidelines. A
senior statistician (EC) did the additional reviews, and
persistently provided suggestions on how to follow reporting
guideline checklists. The manuscript study type determined the
guideline used in the review: STROBE, CONSORT 2001,
23
TREND, STARD, STREGA, and REMARK. The box shows
an example of a review based on reporting guidelines.
Although additional reviews were only sent to authors in the
interventiongroup,theseadditionalreviewsweredoneforevery
paper accepted conditionally in the first editorial decision (fig
1). This step had three purposes: to maintain manuscript flow
throughout the editorial process; to keep the main investigator
masked; and to obtain a score for the initial quality, which was
needed for subsequent random allocation.
The 92 papers eligible for randomisation received a mean of
12.8 (standard deviation 9.6) reviewer suggestions per paper.
Each paper receiving an additional review had 13.5 (3.9)
suggestions,was446(146)wordslong,took28.4(11.2)minutes
to read, and needed 40.8 (15.6) minutes to draft a review. The
reporting guidelines used were: STROBE (85 papers, 92%),
CONSORT(17,18%),TREND(14,15%),STARD(nine,10%),
STREGA(two,2%),andREMARK(one,1%).Forsomepapers,
suggestions related to more than one reporting guideline:
CONSORT,STROBE,andTREND(13papers,14%);STROBE
and STARD (seven, 8%); STROBE and STREGA (two, 2%);
and CONSORT and TREND (one, 1%).
Most suggestions followed the guideline wording very closely
(“STROBE 14: Please provide baseline characteristics of study
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RESEARCHBox: Example of review based on reporting guidelines
In accordance with the STROBE statement applied to cross sectional studies and with the aim of increasing transparency and clarity
(www.strobe-statement.org/Checklist.html), authors should consider the following modifications:
Strobe 3: Please specify secondary objectives. Of the large number of relationships you have studied indicate, where appropriate, which
of them had previous hypotheses. Otherwise, comment on this in the discussion—for example, whether or not these results should be
considered as exploratory.
Strobe 5: Please indicate data collection dates.
Strobe 10: Please specify the reasons for collecting a specific sample size. If it was previously stated, please provide the rationale as
well as either power or accuracy.
Strobe 11: Please explain the rationale for quantitative outcome cut points and whether or not they were previously specified.
Strobe 13: It is implicitly understood that all consecutive patients were selected and all of them agreed to participate. It is also understood
that there are missing data for four deaths only. Please make these points explicit and detail any deviations.
Strobe 16: Please provide 95% confidence intervals for the estimated proportion of the primary objective. If the normal, large sample
approximation cannot be applied, consider exact binomial methods: confidence intervals are especially relevant for small samples.
Strobe 22: If applicable, specify all the sponsors and their control over the publication of results. Clarify similarities and differences with
previous studies.
participants”), but some were more elaborate (“STROBE 12
and 16: Numerical covariates employed for adjusting were
categorised: please check whether you get the same results if
you choose a different cut point, or whether you treat them as
numerical”). The table⇓ classifies the number of suggestions
based on reporting guidelines for every paper section.
Allocation
Before randomisation, all manuscripts were given an ad hoc
assessment by the senior statistician (EC) using a score ranging
from 1 to 9, in order to give a global measure of report quality
at baseline. With these scores, we were able to use a random
minimisation algorithm to balance mean differences in the ad
hoc score as well as differences in study type counts (that is,
intervention, longitudinal, cross sectional, and other type), but
not to equilibrate the overall number of manuscripts in both
groups. The algorithm gave probabilities from 0.5 (in the case
of indifferent allocation to one or another group) to 0.8 (if both
minimisation factors indicated allocation to the same group).
Allocation concealment
The second editorial decision (after peer review and before
randomisation)tookplacewithoutcommitteemembersknowing
which papers were allocated to receive the additional review
(fig1).Atlatereditorialdecisions,committeememberssawthe
additional reviews of papers in the intervention group.
Outcome assessment
Weobtainedthebaselineandfinalscoresbyusingamanuscript
quality assessment instrument, designed by Goodman and
colleagues
24 and used in our previous trial (web table 1).
20 The
instrument uses a 5 point Likert scale from 1 (low) to 5 (high),
and comprises 37 items that assess the quality of the research
report—notthequalityoftheresearchitself.Thefirstitemrefers
to the overall quality of the manuscript (our primary outcome).
Of the remaining 36 specific items, 28 (78%) refer directly to
keyitemsinreportingguidelinesandeight(22%)refertopaper
format and style.
The secondary outcome was the average of all pertinent
items—that is, after excluding specific items that did not apply
tothecurrentstudy.Theevaluatorswerethreejuniorstatisticians
(JC, BK, and LG) with experience in teaching scientific critical
reading to health professionals. The evaluators first rated each
paper individually but, because they were expected to raise
different methodological concerns, they were allowed to know
each other’s opinions before reaching a consensus. If a
consensus was not met, the final score was the average of the
individual scores.
Statistical analyses
Main hypotheses
Themainstatisticalanalysisspecifiedintheprotocolcompared
papers according to their initial allocation (“as allocated”
comparison), adjusted for baseline quality and study type using
an analysis of covariance. We did a secondary “as reviewed”
comparison(thatis,comparingpapersaccordingtothereviews
theyactuallyreceived,irrespectiveofinitialallocation)toassess
the effect of protocol deviations on the conclusion. We also
compared the proportion of papers that improved from the
baseline. The reliability of individual ratings was assessed with
the intraclass correlation coefficient.
Post hoc hypothesis
A statistical researcher (LC) classified, pooled, and masked
reviewer suggestions. Two junior statisticians (BK, LG) then
rated each suggestion’s relevance and the authors’ adherence
in the final manuscript version to each suggestion using two
Likertscales(webtable2).Becausemanuscriptshadadifferent
number of suggestions, the author’s adherence to suggestions
was averaged within the paper and compared between groups
with a t test weighted by the root of the number of suggestions.
We also did an equivalent weighted paired t test to compare the
adherencetoreviewersuggestionsbetweenconventionalreviews
and additional reviews in the intervention group. We fitted a
mixed model with random effects accounting for both reviewer
and author variability to analyse sensitivity to the statistical
analysis.
Sample size calculation indicated that 50 papers per group
allowed 80% power for a 55% standardised difference between
groups, in relation to the mean change in scores from the initial
version to the final version of the paper. In the previous year
(2007), the first editorial decision rejected 186 (57%) of 328
receivedmanuscriptsandtheseconddecisionrejected24(17%)
oftheremaining142;therefore,118papersweresenttoauthors
with reviewer suggestions. Consequently, we defined an entire
year as the recruitment period. For this study, both authors and
refereeswereinformedthattheirmaterialcouldbeusedtoassess
the quality of the editorial process.
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Flow
From May 2008 to April 2009, 126 consecutive original papers
were included in the study (fig 1). Of these papers, 34 (27%)
were rejected on the basis of the conventional review, resulting
in 92 randomised papers. Study types of the included
manuscripts were: 16 (17%) intervention studies, mainly
before-after studies with only five randomised trials; 38 (41%)
longitudinal studies; 26 (28%) cross sectional studies; and 12
(13%) studies of other types (mainly diagnostic studies). We
saw protocol deviations in four papers in the conventional
review group, which underwent an additional review based on
reporting guidelines before the scheduled date (that is, cross-in
manuscripts).
Outcome reliability and validity assessment
Individual ratings before the consensus discussion shared 0.46
of common information (using the intraclass correlation
coefficient). While rating the updated manuscripts, masked
evaluatorsguessedtheallocatedgroupin62%(56/90)ofpapers
(95% confidence interval 51% to 72%; individual percentages
ofsuccess56%(50/90),57%(51/90),and68%(61/90).Overall,
when looking at the author’s adherence to any reviewer
suggestion, the evaluators were also able to guess the
suggestion’s origin (that is, from a conventional review or an
additional review) in 56% (n=855, 95% confidence interval
54% to 59%) of the 1521 suggestions. Evaluators also guessed
whether the type of review was from a clinician or statistician
in 63% (n=961, 61% to 66%) of the suggestions.
Selected papers
According to the ad hoc 1 to 9 scale for baseline quality, the 34
papers rejected after the second editorial decision (fig 1) had
lower mean score than the 92 accepted papers (3.68 (standard
deviation 2.24) v 4.75 (2.20), difference 1.07 (95% confidence
interval 0.19 to 1.95)).
Baseline quality based on 1 to 5 Likert scale
Thegroupsreceivingconventionalreviewsaloneandadditional
reviews had similar mean Goodman scores overall at baseline
(3.00v2.84,fig2⇓).Specificitemsinreportingguidelineswith
high initial scores were oversight (4.54), analysis of multiple
measures (4.05), and organisation (4.04). The worst scoring
itemsweremasking(1.45),dropoutanalysis(1.86),anddropout
description (1.92). Standard deviations of the specific items
varied from 0.69 (oversight) to 1.72 (confidence intervals).
Pooled standard deviations of the overall and average quality
of papers were 1.01 and 0.50, respectively.
Intervention effect
Overall quality (primary outcome) was higher in papers
receivingadditionalreviewsthaninthosereceivingconventional
reviews alone (0.55 (standard deviation 0.83) v 0.27 (0.59);
adjusted improvement 0.25 (95% confidence interval –0.05 to
0.54); fig 3⇓); this difference in quality was significant in the
“as reviewed” population (0.33, 0.03 to 0.63). We obtained
almost identical results for the average quality (secondary
outcome)ofallvaliditems(asallocatedcomparison,0.11(–0.01
to 0.22); as reviewed comparison, 0.15 (0.04 to 0.27)). A post
hoc interaction test showed that additional reviews had an
increased effect on quality of the 16 intervention studies (0.87,
0.01 to 1.74; P=0.04; fig 3).
More papers improved from baseline in overall quality in the
additional review group than in the conventional review group
(22 (43%) v eight (20%); relative risk 2.21, 95% confidence
interval1.10to4.44;difference23.6%,3.2%to44.0%;number
needed to treat 4.2, 2.3 to 31.2; fig 4⇓). This effect increased if
we incorporated the four manuscripts with protocol deviations
into the “as reviewed” analysis (relative risk 3.36, 95%
confidenceinterval1.42to7.99).Theestimatedeffectwasfairly
similar in papers that did or did not include a statistician in the
conventional reviews (data not shown).
Adherence to reviewer suggestions
Since most papers were located above the diagonal line in fig
5⇓, the graph showed that, in the intervention group, authors
adhered more to suggestions from conventional reviews than
to those from additional reviews based on reporting guidelines
(3.08 (0.90) v 2.70 (0.80). The difference was significant in a
weighted paired comparison of means (0.43, 95% confidence
interval 0.19 to 0.67). The weighted correlation between both
adherences was 0.46 (P=0.01), showing the consistency among
authors to consider and to include both kinds of reviewer
suggestions. The estimated weighted mean difference in the
conventionalgroup(3.37)washigherthanthatintheadditional
reviewgroup(3.14),althoughthebetweengroupdifferencewas
notsignificant(0.23;–0.17to0.63).Themixedmodelsensitivity
analysis showed similar results.
Discussion
Summary of findings
Our data indicated that specific reviewer recommendations to
authorsinordertofulfilreportingguidelinesboostedthenumber
of improved papers from 20% to 43% during the peer review
process. But a high proportion of papers (45 (88%), fig 4) did
notreachthemaximumqualityofreporting,basedonGoodman
scoreassessmentsbyjuniorstatisticians.Furthermore,although
the postulated effect on the primary outcome corresponded to
an average improvement of 0.40 on the Likert scale (that is, a
1 point improvement in two of five manuscripts), the observed
improvement was only 0.25 (that is, a 1 point improvement in
oneoffourmanuscripts).Therefore,althoughwehadsecondary
evidence of effect, its size was too small to consider that our
intervention reached its objectives.
The finding that authors adhered more to suggestions from
conventional reviews than to those from additional reviews
invites several interpretations. Firstly, authors might not be
awareofreportingguidelinesinthepreviousphasesofthestudy,
which might make it difficult to incorporate their
recommendations in the report. Secondly, authors might prefer
to concentrate their efforts on more conventional suggestions.
Thirdly, authors in the additional review group might have to
cope with a much higher number of suggestions than authors
in the conventional review group, and could automatically
adhere less to any recommendation, which was supported by
the observed trend towards lower adherence to conventional
suggestions in the additional review group than that in the
conventional review group.
Strengths and limitations of the study
We included any manuscript conditionally accepted after peer
review within the scheduled time window. By following
published guidelines, we also facilitated the definition of our
intervention and its future replication. However, our study had
several limitations. Firstly, the estimated effect could be
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guideline was used in the vast majority of assessments.
However, the observed effect in this type of study was
significantly reduced (fig 3). The increased effect in the 16
intervention studies (fig 3) could be attributed to the longer
tradition of intervention study guidelines.
Secondly, since our trial was conducted in one journal and the
interventionreliedononlyonestatistician,externalvaliditywas
limited.Thirdly,wedesignedamaskedassessmentmethod,but
observed that evaluators were perhaps not completely blinded.
Iftheysubconsciouslyratedmanuscriptshigherintheadditional
review group, the true intervention effect would have been
slightly smaller. Fourthly, we had four protocol deviations; this
number is fairly low if we consider the complexity of the
process, but high enough to complicate the interpretation of the
results.
Furthermore,thesecondeditorialdecisionmeetinghadahigher
rejection rate (27%) than the previous year (17%), resulting in
only92 randomised papersandaslightlylowerpower than that
designed for 100 papers. Finally, although the Goodman score
was especially developed to measure quality improvement
during the peer review process, it has not been updated since
thedevelopmentofreportingguidelines,anditsvalidityhasnot
been formally assessed—probably owing to the absence of a
gold standard. As Friedberg recently highlighted, “developing
useful instruments to measure manuscript quality remains a
huge challenge.”
25 Ultimately, paper quality is a surrogate for
the true purpose of research: to have clarity, transparency,
reproducibility,andimpact,bothonhealthcareandonscientific
research.
Conclusions and policy implications
As mentioned previously, very few randomised trials have
assessed interventions to improve manuscript quality after peer
review. Health research is responsible for improvements in
healthcare. But before implementing its results, the last and
essentialstepiscommunicationanddissemination,whichrelies
on the peer review process. If we want to further improve our
health system, we should develop and select efficient
interventions and accurate prognosis and diagnosis tools. To
avoidpoorhealthresearch,
2 3weneedcompetentcommunication
andeditorialprocesses,withtransparentpublicationsandalow
false discovery rate.
26-29 Although reporting guidelines are a
profoundly reasonable procedure for boosting paper quality,
reasonability does not imply effect.
20
Authors in a mid-level medical journal have more difficulties
in following suggestions based on reporting guidelines than
those from conventional reviews alone. If authors do not
considerkeymethodologicalfeaturesatthedesignandexecution
phases of their study, they will have difficulties in improving
the paper at the later scientific phases. To boost paper quality
and impact, authors should be aware of future requirements of
reporting guidelines at the very beginning of their study, and
peer reviewers should be made aware of the importance of
transparent reporting and receive training if needed.
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RESEARCHTable
Table 1| Total number of suggestions based on reporting guidelines
Total
(N=92)†
STARD (N=9) TREND (N=14) CONSORT plus
extensions (N=17)*
STROBE (N=85) Common and
specific items
n (%) n (%) Item n (%) Item n (%) Item n (%) Item
Title and abstract
76 (72) 1 (11) 1 11 (79) 1 9 (53) 1 53 (62) 1
0 1a
2 (2) 1b
Introduction,
background
14 (14) – – 0 2 1 (6) 2 13 (15) 2
Methods
138 (75) 5 (56) 3 16 (100) 3 11 (65) 3 47 (53) 5 Participants and
recruitment
2 (22) 4 49 (54) 6
4 (5) 6a
0 6b
66 (63) 3 (33) 2 7 (50) 5 7 (41) 5 49 (58) 3 Objectives
Variables,
measurements
20 (13) – – 8 (57) 4 12 (71) 4 – – Interventions
96 (67) 2 (22) 7 6 (36) 6 11 (59) 6 36 (40) 7 Standard,
outcomes
0 8 0 10 31 (35) 8
1 (11) 9
9 (100) 10
108 (92) – – 12 (86) 7 14 (82) 7 81 (95) 10 Sample size
91 (64) 4 (33) 5 2 (14) 8 3 (18) 8 26 (29) 4 Bias,
randomisation,
study design
2 (22) 6 5 (29) 9 44 (51) 9
4 (24) 10
21 (15) 8 (89) 11 3 (14) 9 10 (35) 11 – – Masking
197 (86) 11 (78) 12 18 (93) 11 29 (94) 12 32 (38) 11 Statistical methods
9 (100) 13 77 (60) 12
7 (8) 12a
4 (4) 12b
6 (6) 12e
53 (38) 1 (11) 22 – – 9 (47) 16 25 (30) 12c Missing data
12 (14) 12d
4 (5) 14b
81 (88) – – – – – – 81 (95) 22 Funding
Results
103 (78) 2 (22) 16 6 (43) 12 13 (59) 13 81 (77) 13 Participant flow
30 (26) 2 (22) 14 1 (7) 13 5 (29) 14 18 (20) 14c Recruitment
3 (33) 17
34 (32) 1 (11) 15 0 14 4 (24) 15 23 (26) 14 Baseline data
1 (7) 15 3 (4) 14a
31 (30) 1 (11) 18 1 (7) 16 9 (47) 16 20 (24) 15 Numbers analysed
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RESEARCH(continued)
Total
(N=92)†
STARD (N=9) TREND (N=14) CONSORT plus
extensions (N=17)*
STROBE (N=85) Common and
specific items
n (%) n (%) Item n (%) Item n (%) Item n (%) Item
188 (94) 2 (22) 19 19 (79) 17 25 (88) 17 123 (89) 16 Outcomes and
estimation
4 (44) 21 1 (1) 16a
0 23 0 16b
9 (100) 24 1 (1) 16c
14 (12) – – 1 (7) 18 5 (29) 18 8 (8) 17 Ancillary analyses
31 (23) 7 (78) 20 10 (71) 19 14 (82) 19 – – Adverse events
Discussion
170 (80) – – 4 (21) 20 20 (88) 20 65 (58) 18 Interpretation
80 (71) 19
52 (48) 3 (33) 25 0 21 2 (12) 21 47 (46) 21 Generalisability
86 (66) – – 0 22 3 (18) 22 83 (68) 20 Overall evidence
1700 92 – 126 – 225 – 1236 – Total (100%)
N=total number of manuscripts; n=number of times each reporting guideline item was used (since each item might have more than one suggestion, n can be
greater than N); %=manuscripts with at least one suggestion divided by total number of manuscripts (N).
*Includes CONSORT 2001 and CONSORT for non-pharmacological treatment interventions.
†Two further reporting guidelines were used sporadically: STREGA in two manuscripts with suggestions about participants (three), statistical methods (two),
baseline data (two) and outcomes (two); and REMARK in one manuscript with suggestions about participants (one), sample size (one), study design (one), statistical
methods (four), participant flow (one), recruitment (one), outcomes (two), and interpretation (one).
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RESEARCHFigures
Fig 1 Study design and manuscript flow. *Additional reviews and measurement of minimisation variables were undertaken
during the standard peer review process, but this information was concealed until the later editorial stages
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RESEARCHFig 2 Goodman quality scores at baseline. Bars contain proportion of scores from 1 (dark shade) to 5 (light shade), with
cumulative percentages shown in the bottom scale. Gradation colour for the average quality was consequently adapted
(break points are 2.5, 3.0, 3.5, and 4.0). Dots represent total mean for each specific item
Fig 3 Effect of additional reviews on overall and average quality in “as allocated” and “as reviewed” populations, and primary
analysis stratified by study type
Fig 4 Baseline and final Goodman quality scores in allocated groups. Numbers after the plus signs indicate the four
manuscripts with protocol deviations
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RESEARCHFig 5 Average author adherence to repeated reviewer suggestions based on 5 point Likert scale (1=minimum, 5=maximum).
Rectangles represent the 51 papers from the additional review group, with paired suggestions both from conventional
reviews (shown as the horizontal lines on each rectangle) and additional reviews (shown as the vertical lines of each
rectangle). The side length of rectangles represents the amount of information from any type of review (square root of the
number of suggestions per manuscript) and the rectangle area represents each paper’s overall information. A rectangle
above the diagonal line indicates that a paper adhered more to the conventional review than to the additional review. For
example, the asterisked rectangle corresponds to a manuscript receiving 14 suggestions (proportional to the square of the
vertical sides) from the additional review with a 3.21 average level of adherence, and two suggestions (the square of the
horizontal sides) from the conventional review with a mean adherence score of 5. Lines in the external margin represent
papers from the conventional review group, and lines on the internal margin represent papers from the additional review
group that received both conventional (lines along the vertical axis) and additional (lines along the horizontal axis) reviews;
lines are repeated here to assist between group comparison.
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